Taken together, our results demonstrate that in XLH, impaired 1,25D action due to high serum levels of FGF23, not the direct effects of increased FGF23, underlies the pathogenesis of enthesopathy. The gene discussed is FGF23; the disease is X-linked hypophosphatemia.